XPH - SPDR® S&P® Pharmaceuticals ETF (USD) (US78464A7220)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

Alle auswählen Alle zurücksetzen

Speichern Schließen

(%)

US78464A7220

XPH ISIN

Exchange Traded Funds (ETF)

Fondstyp

SPDR State Street Global Advisors

Anbieter

67,34 USD

NAV pro Aktie | 16/07/2026

16/06/2006

Startdatum

4 Wiederholungen pro Jahr

Ausschüttung von Dividenden

CEOILS

CFI

XPH

Ticker

Formed

Status

Equity

Investitionsobjekt

Healthcare

Sektor

USA

Geographie

S&P Pharmaceuticals Select Industry Index

Benchmark

0.35 %

Gesamtkostenquote

464,66 Mio. USD

Gesamtes Fondsvermögen | 16/07/2026

464,66 Mio. USD

Aktien-Anlageklasse Volumen | 16/07/2026

Nein

UCITS

Rendite auf 17/07/2026, NYSE Arca

YTD

1,13 %
1M

-5,91 %
3M

-2,73 %
6M

7,29 %
1J

38,48 %
3J

42,34 %
5J

18,07 %
10J

47,64 %

Zum Börsenpreis einschliesslich Einkommenszahlungen

Letzte Daten zum

Zum Vergleichen hinzufügen

Kurse (XPH)

Entdecken Sie die umfangreichste Datenbank

1 000 000

Anleihen weltweit

100 000

Aktien

175 910

ETF & Funds

100 000

Indizes

Verwalten Sie Ihr Portfolio auf effizienteste Weise

Bond-Screener
Watchlist
Excel-Add-In

Zugang erhalten

Kurs-Dynamik

Fund profile

The SPDR S&P Pharmaceuticals ETF seeks to replicate as closely as possible the price and yield performance of the S&P Pharmaceuticals Select Industry Index by investing in a portfolio comprised primarily of U.S. companies in the pharmaceutical industry

XPH profile

The SPDR® S&P® Pharmaceuticals ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Healthcare sector located in USA. The SPDR State Street Global Advisors fund’s base currency is USD and the share class was registered 16.06.2006 with unique ISIN - US78464A7220. Main exchange is NYSE Arca and ticker symbol is XPH. The total expense ratio is 0.35%. The SPDR® S&P® Pharmaceuticals ETF (USD) pays dividends 4 time(s) per year.

Struktur XPH auf 16/07/2026

Struktur in Excel herunterladen

Wertpapier	Wertpapier
CRINETICS PHARMACEUTICALS IN	3,74%
DEFINIUM THERAPEUTICS INC	2,9%
ATAIBECKLEY INC	2,89%
MBX BIOSCIENCES INC	2,88%
ENLIVEN THERAPEUTICS INC	2,1%
ALUMIS INC	2,07%
TREVI THERAPEUTICS INC	1,98%
AMYLYX PHARMACEUTICALS INC	1,93%
HARROW INC	1,91%
NUVATION BIO INC	1,88%
LIGAND PHARMACEUTICALS	1,83%
NEKTAR THERAPEUTICS	1,81%
AMNEAL PHARMACEUTICALS INC	1,8%
EDGEWISE THERAPEUTICS INC	1,77%
LIQUIDIA CORP	1,76%
CORCEPT THERAPEUTICS INC	1,76%
VERADERMICS INC	1,74%
ELANCO ANIMAL HEALTH INC	1,73%
MAZE THERAPEUTICS INC	1,69%
VIATRIS INC	1,68%
PACIRA BIOSCIENCES INC	1,67%
BRISTOL MYERS SQUIBB CO	1,66%
ROYALTY PHARMA PLC CL A	1,64%
MERCK + CO. INC.	1,64%
SUPERNUS PHARMACEUTICALS INC	1,63%
INDIVIOR PHARMACEUTICALS INC	1,63%
EYEPOINT INC	1,62%
JAZZ PHARMACEUTICALS PLC	1,61%
OCULAR THERAPEUTIX INC	1,6%
JOHNSON + JOHNSON	1,6%
COLLEGIUM PHARMACEUTICAL INC	1,59%
PRESTIGE CONSUMER HEALTHCARE	1,57%
ELI LILLY + CO	1,57%
ORGANON + CO	1,54%
WAVE LIFE SCIENCES LTD	1,53%
XERIS BIOPHARMA HOLDINGS INC	1,53%
ANI PHARMACEUTICALS INC	1,53%
PERRIGO CO PLC	1,53%
PFIZER INC	1,5%
INNOVIVA INC	1,48%
AXSOME THERAPEUTICS INC	1,47%
ZOETIS INC	1,45%
HARMONY BIOSCIENCES HOLDINGS	1,44%
TARSUS PHARMACEUTICALS INC	1,44%
PHIBRO ANIMAL HEALTH CORP A	1,41%
RAPPORT THERAPEUTICS INC	1,39%
OMEROS CORP	1,38%
BIOAGE LABS INC	1,36%
ETON PHARMACEUTICALS INC	1,34%
AMPHASTAR PHARMACEUTICALS IN	1,23%
ALTO NEUROSCIENCE INC	1,22%
ARVINAS INC	1,21%
ZEVRA THERAPEUTICS INC	1,1%
PHATHOM PHARMACEUTICALS INC	1,08%
CORMEDIX INC	1,07%
THERAVANCE BIOPHARMA INC	0,96%
SEPTERNA INC	0,93%
ACLARIS THERAPEUTICS INC	0,91%
RELMADA THERAPEUTICS INC	0,84%
LB PHARMACEUTICALS INC	0,75%
AQUESTIVE THERAPEUTICS INC	0,73%
FULCRUM THERAPEUTICS INC	0,66%
LEXICON PHARMACEUTICALS INC	0,59%
EVOLUS INC	0,43%
SSI US GOV MONEY MARKET CLASS	0,07%
CONTRA ESPERION THERAP	0,01%
US DOLLAR	0%

Alle anzeigen Verstecken

Andere - %